DISCOUNT-ZERTIFIKAT - NOVARTIS N Share Price

Certificat

DE000SU0DWV7

Market Closed - Deutsche Boerse AG 20:47:36 24/05/2024 BST
85.38 EUR -0.40% Intraday chart for DISCOUNT-ZERTIFIKAT - NOVARTIS N
Current month-0.49%
1 month-0.72%
Date Price Change
24/05/24 85.38 -0.40%
23/05/24 85.72 +0.20%
22/05/24 85.55 -0.19%
21/05/24 85.71 -0.01%
20/05/24 85.72 -0.07%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 08:47 pm

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer Société Générale Société Générale
WKN SU0DWV
ISINDE000SU0DWV7
Date issued 06/10/2023
Cap 85 CHF
Last trading day 20/06/2024
Maturity 21/06/2024 (26 Days)
Parity 1 : 1
Emission price 81.9
Emission volume N/A
Payment day 28/06/2024
Bonus-
Settlement les deux
Currency EUR

Technical Indicators

Discount (ask) 0.000000 %
Sideways yield 0.000000 %
Sideways yield pa 0.000000 %
Outperformance point- CHF
Break even 0.000000 €
Highest since issue 89.18
Lowest since issue 80.73
Spread 0.13
Spread %0.15%
Distance Cap 6.74 CHF
Distance Cap %+7.35%
Max. earning-
Max. earning % 0.000000 %

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
100.4 USD
Average target price
108 USD
Spread / Average Target
+7.64%
Consensus